Extracellular vesicles released by steatotic hepatocytes alter adipocyte metabolism.

Zucker model adipocytes exosomes extracellular vesicles hepatocytes inflammation liver steatosis metabolic syndrome microvesicles obesity

Journal

Journal of extracellular biology
ISSN: 2768-2811
Titre abrégé: J Extracell Biol
Pays: United States
ID NLM: 9918382980506676

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 21 10 2021
revised: 13 01 2022
accepted: 26 01 2022
medline: 15 3 2022
pubmed: 15 3 2022
entrez: 28 6 2024
Statut: epublish

Résumé

The composition of extracellular vesicles (EVs) is altered in many pathological conditions, and their molecular content provides essential information on features of parent cells and mechanisms of crosstalk between cells and organs. Metabolic Syndrome (MetS) is a cluster of clinical manifestations including obesity, insulin resistance, dyslipidemia and hypertension that increases the risk of cardiovascular disease and type 2 diabetes mellitus. Here, we investigated the crosstalk between liver and adipocytes by characterizing EVs secreted by primary hepatocytes isolated from Zucker rat model, and studied the effect they have on 3T3-L1 adipocytes. We found that steatotic hepatocytes secrete EVs with significantly reduced exosomal markers in comparison with their lean counterpart. Moreover, proteomic analysis revealed that those EVs reflect the metabolic state of the parent cell in that the majority of proteins upregulated relate to fat metabolism, fatty acid synthesis, glycolysis, and pentose phosphate pathway. In addition, hepatocytes-secreted EVs influenced lipolysis and insulin sensitivity in recipient 3T3-L1 adipocytes. Untargeted metabolomic analysis detected alterations in different adipocyte metabolic pathways in cells treated with hepatic EVs. In summary, our work showed that steatosis has a significant impact in the amount and composition of EVs secreted by hepatocytes. Moreover, our data point to the involvement of hepatic-EVs in the development of pathologies associated with MetS.

Identifiants

pubmed: 38938664
doi: 10.1002/jex2.32
pii: JEX232
pmc: PMC11080919
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e32

Informations de copyright

© 2022 The Authors. Journal of Extracellular Biology published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.

Déclaration de conflit d'intérêts

None.

Auteurs

J E Mleczko (JE)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.
Department of Neurology Alzheimer's Disease Research Center Icahn School of Medicine at Mount Sinai New York New York USA.

F Royo (F)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.
Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain.

I Samuelson (I)

TVP Lab Wellcome/MRC Institute of Metabolic Science MRC Metabolic Diseases Unit - Metabolic Research Laboratories University of Cambridge Cambridge UK.

M Clos-Garcia (M)

Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) Faculty of Health and medical Sciences University of Copenhagen Copenhagen Denmark.

C Williams (C)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

D Cabrera (D)

Metabolomics Platform Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

M Azparren-Angulo (M)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

E Gonzalez (E)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

C Garcia-Vallicrosa (C)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

S Carobbio (S)

TVP Lab Wellcome/MRC Institute of Metabolic Science MRC Metabolic Diseases Unit - Metabolic Research Laboratories University of Cambridge Cambridge UK.

S Rodriguez-Cuenca (S)

TVP Lab Wellcome/MRC Institute of Metabolic Science MRC Metabolic Diseases Unit - Metabolic Research Laboratories University of Cambridge Cambridge UK.

M Azkargorta (M)

Proteomics Platform Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

S van Liempd (S)

Metabolomics Platform Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

F Elortza (F)

Proteomics Platform Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.

A Vidal-Puig (A)

TVP Lab Wellcome/MRC Institute of Metabolic Science MRC Metabolic Diseases Unit - Metabolic Research Laboratories University of Cambridge Cambridge UK.

S Mora (S)

Department of Biochemistry and Molecular Biomedicine University of Barcelona Barcelona Spain.

J M Falcon-Perez (JM)

Exosomes Laboratory Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.
Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain.
Metabolomics Platform Center for Cooperative Research in Biosciences (CIC bioGUNE) Basque Research and Technology Alliance (BRTA) Derio Bizkaia Spain.
IKERBASQUE Basque Foundation for Science Bilbao Bizkaia Spain.

Classifications MeSH